BML Investment Partners, L.P. 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-10 5:39 pm Purchase | 2024-01-10 | 13D | Forte Biosciences, Inc. FBRX | BML Investment Partners, L.P. | 70,468 4.800% | 1,065 (+1.53%) | Filing |
| 2023-09-15 12:00 pm Unchanged | 2023-09-15 | 13D | Forte Biosciences, Inc. FBRX | BML Investment Partners, L.P. | 69,403 4.780% | 0 (Unchanged) | Filing |
| 2023-03-29 11:17 am Purchase | 2023-03-24 | 13D | Forte Biosciences, Inc. FBRX | BML Investment Partners, L.P. | 69,403 8.260% | 10,948 (+18.73%) | Filing |
| 2022-08-16 08:22 am Purchase | 2022-08-15 | 13D | Forte Biosciences, Inc. FBRX | BML Investment Partners, L.P. | 58,455 7.200% | 4,759 (+8.86%) | Filing |
| 2022-07-07 08:22 am Purchase | 2022-07-06 | 13D | Forte Biosciences, Inc. FBRX | BML Investment Partners, L.P. | 53,696 9.100% | 896 (+1.70%) | Filing |
| 2022-05-24 12:19 pm Purchase | 2022-05-24 | 13D | Forte Biosciences, Inc. FBRX | BML Investment Partners, L.P. | 52,800 8.940% | 17,250 (+48.52%) | Filing |
| 2022-05-04 11:00 am Purchase | 2022-04-26 | 13G | Forte Biosciences, Inc. FBRX | BML Investment Partners, L.P. | 35,550 6.000% | 35,550 (New Position) | Filing |